We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging

By LabMedica International staff writers
Posted on 11 Jun 2026

Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. More...

However, few investigations have directly examined blood plasma vitamin C in relation to brain structure or connectivity within large-scale networks. Clarifying such relationships may inform understanding of cognitive function in aging. A new study now shows that plasma vitamin C levels are associated with gray matter volume and default mode network connectivity in older adults.

Hirosaki University (Hirosaki, Japan) researchers analyzed magnetic resonance imaging (MRI) scans and blood plasma vitamin C levels from a community cohort of older Japanese adults. The analysis focused on gray and white matter volume and structural connectivity within the default mode network (DMN), a set of regions linked to attention and autobiographical memory. Investigators adjusted for age, physical activity, education, and other factors that can affect brain structure or connectivity. The work identifies statistical associations between plasma vitamin C and MRI-derived neuroanatomical features.

The observational analysis included 2,044 participants over the age of 64. For each participant, the team quantified gray and white matter volumes while accounting for individual differences in total brain volume. They also evaluated connectivity within the DMN. After statistical adjustment for potential confounders, lower plasma vitamin C levels were linked to lower gray matter volume and reduced DMN connectivity.

The findings were published in PLOS One on June 10, 2026. The authors note that the associations do not establish causation and that further work is required to elucidate underlying biological mechanisms. Suggested next steps include repeated plasma vitamin C measurements over time, broader accounting for lifestyle and nutritional variables, and inclusion of participants from additional ethnic and socioeconomic backgrounds. The results suggest the possibility that optimal plasma vitamin C could potentially support cognitive function in aging, while underscoring the need for prospective research.

“Our study demonstrates that higher plasma vitamin C levels are associated with better preserved structural connectivity of the default mode network (DMN), a key brain network involved in cognitive function. This finding generates the exciting hypothesis that a diet rich in vitamin C might play a supportive role in maintaining brain health and mitigating age-related cognitive decline in older adults,” said Tomohiro Shintaku, Department of Radiology, Graduate School of Medicine, Hirosaki University.

Related Links
Hirosaki University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

For women with early-stage invasive breast cancer who undergo breast-conserving surgery, clinicians must assess both the risk of locoregional recurrence and the potential benefit of adjuvant radiation therapy.... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.